http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33062097

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 1496
issn 1387-2877
1875-8908
issueIdentifier 4
pageRange 1489-1496
publicationName Journal of Alzheimer's disease : JAD
startingPage 1489
bibliographicCitation Carmona-Iragui M, Santos T, Videla S, Fernández S, Benejam B, Videla L, Alcolea D, Blennow K, Blesa R, Lleó A, Fortea J. Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Subjects with Down Syndrome. J Alzheimers Dis. 2017;55(4):1489–96. doi: 10.3233/jad-160827. PMID: 27858714.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3819-3245
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1840038e9065a932c4a89a139062ea25
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d10e797c5a11b10d0a39922975ed5883
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_40afc416014b85a541b17f5333c82277
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae6d1e8c34aba73881dc30dffe5a28e8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a073b4747b3f36d8eb5d2f548f9ebba
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_746294365f17ac4423491e057bf12672
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd24470cc651002164bc19ed83cee10a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_551529ae306c208d4391af3a2249d3d6
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bd2a576e576d63764b9b88f9aeb96ac7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79cfd45c9026a338afaf59a15e360c35
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9234ad89ef6da65d08badaa3057467c
date 2016-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/27858714
https://doi.org/10.3233/jad-160827
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1387-2877
https://portal.issn.org/resource/ISSN/1875-8908
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Feasibility of Lumbar Puncture in the Study of Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in Subjects with Down Syndrome
discusses http://id.nlm.nih.gov/mesh/M0023752
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000544Q000150
http://id.nlm.nih.gov/mesh/D004314Q000134
http://id.nlm.nih.gov/mesh/D015415Q000134
http://id.nlm.nih.gov/mesh/D004314Q000150
http://id.nlm.nih.gov/mesh/D013129Q000379
http://id.nlm.nih.gov/mesh/D000544Q000134
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000328
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D005240
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D012189
http://id.nlm.nih.gov/mesh/D008297
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7008
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64747
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7488
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907

Total number of triples: 52.